An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...
With pancreatic cancer being one of the deadliest cancers, the ability to catch lesions early could save lives, especially given the disease's high mortality rates. "Our work suggests that integrating ...
Please provide your email address to receive an email when new articles are posted on . Pancreatic cancer is among the deadliest malignancies, and those who specialize in its treatment eagerly embrace ...
A thumbnail-sized chip detected pancreatic cancer from blood plasma with 97% accuracy, beating the standard needle biopsy (79%).
To spot breast cancer early, there are mammograms. To find colon cancer early, there are colonoscopies. But there is no standard test to detect early cases of pancreatic cancer, before cancer cells ...
San Diego — A liquid biopsy assay that combines a microRNA signature and a well-known biomarker for pancreatic cancer has demonstrated an accuracy of 97% for detecting stage I/II pancreatic ductal ...
Post-progression therapies and outcomes for patients with advanced, BRCA-related pancreatic cancer after receipt of PARP inhibitors: A national retrospective cohort study. This is an ASCO Meeting ...
Share on Pinterest An experimental new pill, daraxonrasib, significantly improved survival rates of participants with pancreatic cancer. Israel Sebastian/Getty Images A new medication performed ...
Development of a National Cancer Registry in a Low Resourced Country: The Case of Kenya National Cancer Registry Programme Background: Pancreatic cancer is the fourth leading cause of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results